Clinical Trial Update: Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intrathecal chemotherapy delivered via an Ommaya reservoir for HER2-negative breast cancer with leptomeningeal metastasis; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leptomeningeal Carcinomatosis

Snippet

Sponsor: Fudan University | Conditions: HER2-negative Breast Cancer, Leptomeningeal Metastasis | Phase 4 | Status: RECRUITING